Barts Cancer Institute (BCI) is one of the top cancer research centres in the UK and, within the Barts Centre, is part of the national Cancer Research UK Centres network. BCI was created in 2003, and...
Barts Cancer Institute (BCI) is one of the top cancer research centres in the UK and, within the Barts Centre, is part of the national Cancer Research UK Centres network. BCI was created in 2003, and brought together some of the most eminent cancer research teams in London. We are one of the six Institutes within the Barts and The London School of Medicine and Dentistry, Queen Mary University of London. Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, we have created an academic environment fitting for an internationally recognised, comprehensive cancer centre. BCI, as part of the Barts and The London School of Medicine and Dentistry, is in the top 10 multi-faculty research institutions (REF 2014). We are generously supported by research councils, industry, and a host of charities, with the grants awarded totalling in excess of £15m per year. Our research goal is to prevent cancer and develop better diagnostic techniques and treatments. Ultimately we aim to improve survival for people with cancer and enhance the quality of life for those with long-term disease. BCI, as part of the Barts and The London School of Medicine and Dentistry, is in the top 10 multi-faculty research institutions (REF 2014). We also use our expertise to teach and educate students and professionals about the science of and gold-standard clinical approaches to cancer, and to engage our local population. We hope to make the often difficult subject of cancer accessible to anyone that requires or is interested in our research.